Zy Therapeutics

Zy TherapeuticsZy TherapeuticsZy Therapeutics

Zy Therapeutics

Zy TherapeuticsZy TherapeuticsZy Therapeutics
  • Home
  • About
  • Who We Are
  • Corporate Communications
  • Contact Us
  • More
    • Home
    • About
    • Who We Are
    • Corporate Communications
    • Contact Us
  • Home
  • About
  • Who We Are
  • Corporate Communications
  • Contact Us

Tracy Jerome (“TJ”) Stalvey

Chief Operating Officer

.

  • 30+ years in life sciences , including hospital, university, global CRO, biotechnology, and start up environments


  • Clinical program development (concept to market)


  • Direct patient facing experience; working with physician researchers, KOLs, healthcare executives


  • Consulting with investors and entrepreneurs


  • Managing co development financial partnerships, open innovation and joint development objectives


  • Portfolio management at global CROs


  • Pharma product lifecycle strategic marketing roles; new delivery mechanisms and indications


  • Multiple successful rare and orphan disease program delivery and regulatory filings, 505(b)(2)


  • Strategic partnership management (sponsor and CRO); outsourcing strategy and cost reduction modeling

Zy Therapeutics

Copyright © 2025 Zy Therapeutics - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept